法信諾生醫股份有限公司
Update：2025/12/24
Industries
Main Industry
Health Care
Main Product/Service
1. COVID-19 Vaccine (V-CO)
2. Nucleic acid medicine- V-ADmir
3. Brain Delivery Platform- VBT
2. Nucleic acid medicine- V-ADmir
3. Brain Delivery Platform- VBT
Founded Year
2020
Unified Business No.
83702127
Status
Active
Number of Employees
0
Total Paid-in
Capital
36,500,000 (NT$)
Location of Company
Taiwan
, Taipei City
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Exclusive content for members
Members-only content. Please log in to access.
Introduction
Founded in July 2020, Vacino Biotech is committed to the development of novel nucleic acid drugs and universal vaccines. With the self-developed next-generation vaccine design SED technology, we have invested in the development of COVID-19 T-cell vaccine
